Journal
Neurology Genetics
Publication Date
2019
Volume
5
Issue
2
Inclusive Pages
e318
Document Type
Open Access Publication
DOI
10.1212/NXG.0000000000000318
Rights and Permissions
Findlay AR, Bengoechea R, Pittman SK, Chou TF, True HL, Weihl CC. Lithium chloride corrects weakness and myopathology in a preclinical model of LGMD1D. Neurol Genet. 2019 Apr;5(2):e318. doi: 10.1212/NXG.0000000000000318. Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Recommended Citation
Findlay, Andrew R.; Bengoechea, Rocio; Pittman, Sara K.; Chou, Tsui-Fen; True, Heather L.; and Weihl, Conrad C., "Lithium chloride corrects weakness and myopathology in a preclinical model of LGMD1D." Neurology Genetics. 5, 2. e318. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7816
